Systems Diagnostics – Real Personalized Medicine: David de Graaf, PhD, CEO, Selventa Inc. | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Advertisements

Feeds:: Posts; Comments

« Ranking Drugs and Predicting Side Effects using Systems Pharmacology: Jake Y Chen, PhD

Molecular Profiling in Cancer Immunotherapy: Debraj GuhaThakurta, PhD »

Systems Diagnostics – Real Personalized Medicine: David de Graaf, PhD, CEO, Selventa Inc.

April 22, 2013 by 2012pharmaceutical

Reporter: Aviva Lev-Ari, PhD, RN

Systems Pharmacology – Pathways to Patient Response @ BioIT World, April 9-11, 2013, World Trade Center, Boston, MA

David de Graaf, PhD’s presentation at the conference is to be viewed at the link, below

http://www.chiresource.com/BIT-05-23/Presentations/NPC/deGraaf_David.pdf

Advertisements

Posted in Personalized and Precision Medicine & Genomic Research, Pharmaceutical Analytics, Pharmaceutical Industry Competitive Intelligence, Pharmaceutical R&D Investment, Pharmacogenomics | 1 Comment

One Response

on September 4, 2013 at 2:12 AM | Reply Issues in Personalized Medicine: Discussions of Intratumor Heterogeneity from the Oncology Pharma forum on LinkedIn | Pharmaceutical Intelligence

[…] Systems Diagnostics – Real Personalized Medicine: David de Graaf, PhD, CEO, Selventa Inc. […]

Leave a Reply Cancel reply

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Google account. ( Log Out / Change )

You are commenting using your Twitter account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

Connecting to %s

%d bloggers like this: